Elizabeth Steiner Elmazahi

Elizabeth Steiner Elmazahi serves as a Procurement Analyst responsible for supporting the acquisition lifecycle of mission-critical goods and services within her agency. She plays a pivotal role in ensuring compliance with federal procurement regulations, preparing solicitation documents, evaluating vendor proposals, and facilitating contract award actions. Her work directly supports the agency’s mission by securing specialized technical solutions through competitive and socioeconomic procurement pathways. She typically handles complex acquisitions in biopharmaceutical manufacturing and custom software development, requiring deep technical understanding and careful market analysis to meet stringent regulatory and performance requirements. While specific contractor names are not available, her procurement patterns indicate consistent engagement with a diverse pool of vendors, including both large-capability firms and small businesses certified under federal socioeconomic programs. She fosters collaborative relationships with suppliers capable of delivering high-compliance, low-risk solutions, often requiring rigorous quality control, data integrity, and regulatory adherence. Her approach emphasizes transparency, competition, and vendor accountability throughout the sourcing process. Elizabeth demonstrates a strong commitment to small business participation, with approximately one-third of her awards directed toward 8(a) competed set-asides, reflecting a deliberate effort to expand opportunities for disadvantaged businesses. The remaining two-thirds of her acquisitions are competed broadly without set-aside restrictions, indicating a balanced strategy that prioritizes both socioeconomic goals and market-wide competition to ensure optimal value and capability. Her primary procurement focus lies in NAICS 325414 (Biological Product Manufacturing) and 541511 (Custom Computer Programming Services), underscoring her expertise in procuring therapeutic biologics, laboratory reagents, and bespoke software systems for data management, analytics, or regulatory compliance. She is well-versed in the technical and regulatory demands of life sciences and software development domains, ensuring that acquisitions align with operational needs, federal standards, and emerging technological capabilities.